AMPK: a novel target for treating hepatic fibrosis.
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.19376
Abstract: Fibrosis is a common process of excessive extracellular matrix (ECM) accumulation following inflammatory injury. Fibrosis is involved in the pathogenesis of almost all liver diseases for which there is no effective treatment. 5'-AMP-activated protein kinase… read more here.
Keywords: fibrosis; ampk novel; novel target; hepatic fibrosis ... See more keywords